Trial tests less frequent dosing for blood cancer treatment
NCT ID NCT07014917
Summary
This study is testing whether taking one of two drugs less often works as well as taking it continuously for people with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). About 62 participants will be randomly assigned to receive the drug combination on either a weekly or a daily schedule. The main goal is to see if the less frequent schedule can still put the cancer into complete remission while potentially reducing side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45219, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.